JP4521687B2 - プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２ - Google Patents

プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２ Download PDF

Info

Publication number
JP4521687B2
JP4521687B2 JP2004514431A JP2004514431A JP4521687B2 JP 4521687 B2 JP4521687 B2 JP 4521687B2 JP 2004514431 A JP2004514431 A JP 2004514431A JP 2004514431 A JP2004514431 A JP 2004514431A JP 4521687 B2 JP4521687 B2 JP 4521687B2
Authority
JP
Japan
Prior art keywords
propionibacterium
vitamin
strains
food
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004514431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529960A (ja
JP2005529960A5 (https=
Inventor
アダムス，ミケル，キャサリン
ウァング，ヤング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newcastle Innovation Ltd
Original Assignee
Newcastle Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPS3124A external-priority patent/AUPS312402A0/en
Priority claimed from AUPS3152A external-priority patent/AUPS315202A0/en
Priority claimed from AU2002952793A external-priority patent/AU2002952793A0/en
Application filed by Newcastle Innovation Ltd filed Critical Newcastle Innovation Ltd
Publication of JP2005529960A publication Critical patent/JP2005529960A/ja
Publication of JP2005529960A5 publication Critical patent/JP2005529960A5/ja
Application granted granted Critical
Publication of JP4521687B2 publication Critical patent/JP4521687B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/61—Propionibacterium
    • A23V2400/619—Jensenii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
JP2004514431A 2002-06-21 2003-06-20 プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２ Expired - Fee Related JP4521687B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPS3124A AUPS312402A0 (en) 2002-06-21 2002-06-21 Probiotic propionibacterium
AUPS3152A AUPS315202A0 (en) 2002-06-24 2002-06-24 Probiotic propionibacterium
AU2002952793A AU2002952793A0 (en) 2002-11-18 2002-11-18 Oral vaccination
PCT/AU2003/000775 WO2004001022A1 (en) 2002-06-21 2003-06-20 Probiotic propionibacterium jensenii 702

Publications (3)

Publication Number Publication Date
JP2005529960A JP2005529960A (ja) 2005-10-06
JP2005529960A5 JP2005529960A5 (https=) 2006-08-24
JP4521687B2 true JP4521687B2 (ja) 2010-08-11

Family

ID=30003395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514431A Expired - Fee Related JP4521687B2 (ja) 2002-06-21 2003-06-20 プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２

Country Status (5)

Country Link
US (1) US7427397B2 (https=)
EP (1) EP1527159A4 (https=)
JP (1) JP4521687B2 (https=)
NZ (1) NZ537242A (https=)
WO (1) WO2004001022A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175305A1 (en) * 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US7291326B2 (en) 2003-01-06 2007-11-06 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US8337861B2 (en) * 2003-01-09 2012-12-25 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
WO2007070518A2 (en) * 2005-12-13 2007-06-21 The Trustees Of The University Of Pennsylvania Bacteria-derived blis for treatment of acne
WO2008028146A2 (en) * 2006-09-01 2008-03-06 Wisconsin Alumni Research Foundation Novel protein compositions and systems for expression of desaturases
JP2008118908A (ja) * 2006-11-10 2008-05-29 Canon Inc プローブ、プローブセット、プローブ固定担体及び遺伝子検査方法
EP1952703B1 (de) * 2007-02-02 2010-08-25 May, Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
FR2921795B1 (fr) * 2007-10-03 2011-04-29 Gervais Danone Sa Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
KR20170059011A (ko) * 2007-11-27 2017-05-29 가부시키가이샤 메이지 유산균의 생잔성 향상제 및 생잔성 향상 방법, 및 식품 조성물
NZ596979A (en) * 2008-02-29 2012-06-29 Meiji Co Ltd Anti-allergic agent comprising a fermentation product of a propionic acid bacterium
AU2015200625B2 (en) * 2008-03-07 2017-03-16 Megmilk Snow Brand Co., Ltd. Agents for promoting secretion and/or suppressing decrease of adiponectin
NZ587285A (en) * 2008-03-07 2013-08-30 Bongrain Sa Agents for promoting secretion and/or suppressing decrease of adiponectin
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
EP2245944A1 (fr) * 2009-04-30 2010-11-03 Danisco A/S Procédé pour améliorer la digestibilité et l'assimilabilité des céréales et/ou des fibres chez un animal herbivore monogastrique
UY32802A (es) * 2009-07-23 2011-01-31 Provimi Holding B V Composiciones para reducir la metanogénesis gastrointestinal en rumiantes
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9961914B2 (en) 2010-12-07 2018-05-08 Purac Biochem Bv Fruit ferments containing propionate and use thereof
JP5818309B2 (ja) * 2011-03-23 2015-11-18 株式会社明治 血中コレステロール低減剤
WO2014001102A1 (de) * 2012-06-26 2014-01-03 Uniwersytet Przyrodniczy W Poznaniu Propionibakterienstamm propionibacterium freundenreichii kt 021
JP5882177B2 (ja) * 2012-10-19 2016-03-09 株式会社日立製作所 生体物質回収方法及び生体物質回収装置
WO2014098764A1 (en) * 2012-12-21 2014-06-26 Conifer Living Formulas Pte Ltd Topical treatment delivery system
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US20150352162A1 (en) 2013-01-21 2015-12-10 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
ES3025685T3 (en) 2014-06-17 2025-06-09 Crown Laboratories Inc Genetically modified bacteria and methods for genetic modification of bacteria
CN107404925A (zh) 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
WO2016168729A1 (en) * 2015-04-17 2016-10-20 Evolve Biosystems Inc. Delivering non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tube
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2016183319A1 (en) * 2015-05-13 2016-11-17 University Of Florida Research Foundation, Incorporated Propionibacterium fruedenreichii as a probiotic for infants
GB201509023D0 (en) * 2015-05-27 2015-07-08 Optibiotix Ltd Compositions and methods of production thereof
JP6262412B1 (ja) * 2016-04-14 2018-01-17 株式会社明治 発酵乳の製造における発酵時間の短縮方法、及び発酵乳における酸味の上昇の抑制方法
RU2631607C1 (ru) * 2016-11-22 2017-09-25 Владислав Николаевич Ласкавый Средство для профилактики лейкоза крупного рогатого скота и способ его применения
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN106587342A (zh) * 2016-12-29 2017-04-26 中国科学院城市环境研究所 一种生物修复试剂及其在去除复合污染水体中1,2‑二氯乙烷中的应用
US11571387B2 (en) * 2017-03-27 2023-02-07 Praj Industries Limited Process for the preparation of powdered probiotic formulations for monogastric animals
WO2018217764A1 (en) * 2017-05-22 2018-11-29 Kansas State University Research Foundation Microbiome transplantation
US12285437B2 (en) 2019-10-30 2025-04-29 The Research Foundation For The State University Of New York Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity
CA3183350A1 (en) * 2020-06-23 2021-12-30 Thomas M. Hitchcock Probiotic skin formulations
WO2022124324A1 (ja) * 2020-12-09 2022-06-16 株式会社明治 アシディプロピオニバクテリウム属菌またはその処理物を含んでなる組成物
US20220367050A1 (en) * 2021-05-12 2022-11-17 Zoe Limited Predicting gut microbiome diversity
CN114216982B (zh) * 2021-12-14 2024-08-09 黑龙江飞鹤乳业有限公司 维生素b12的检测方法
CN114540235B (zh) * 2022-03-04 2023-10-31 中国海洋大学 一种诱导乳酸菌休眠态的方法及其应用
WO2026057677A1 (en) 2024-09-11 2026-03-19 Unikline B.V. A novel composition comprising adenosyl cobalamin
CN120173826B (zh) * 2025-05-20 2025-08-01 造益(昆山)生物科技有限公司 耐温费氏丙酸杆菌谢氏亚种菌株pf37及其在肠道定植共生的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5937076B2 (ja) 1977-05-26 1984-09-07 日石三菱株式会社 醗酵法ビタミンｂ↓１↓２の製法
US4981705A (en) * 1989-11-06 1991-01-01 Pioneer Hi-Bred International, Inc. Bacterial treatment to preserve silage
US5639659A (en) * 1992-12-29 1997-06-17 Clemson University Process for inhibiting the growth of bacteria using bacteriocins produced by Propionibacterium jensenii strain ATCC 4872
DE19630230A1 (de) 1996-07-26 1998-01-29 Bayer Ag Herstellung immunstimulierender Mittel auf Basis von Propionibakterien
US6221847B1 (en) * 1996-09-13 2001-04-24 Clemson University Composition and method for treating bacterial infection
US5989612A (en) * 1996-10-11 1999-11-23 Rodia Inc. Foods including antimycotic agent
JPH11171783A (ja) 1997-08-15 1999-06-29 Vetoquinol Sa 所定の動物に関して細胞性免疫と体重増加を生じる濃度でのバクテリアの経口投与
US6019985A (en) 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
WO1999053775A1 (en) * 1998-04-17 1999-10-28 The Board Of Regents For Oklahoma State University Propionibacterium p-63 for use in direct fed microbials for animal feeds
US6262019B1 (en) 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
KR20010075495A (ko) 1998-10-01 2001-08-09 추후보정 산화성 스트레스 인자의 감소
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US6951643B2 (en) * 2001-07-24 2005-10-04 Oklahoma State University Direct-fed microbial
EP1308506A1 (en) * 2001-11-06 2003-05-07 Eidgenössische Technische Hochschule Zürich Mixtures of Propionibacterium jensenii and Lactobacillus sp. with antimicrobial activities for use as a natural preservation system
EP1374878A1 (en) 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
CN1317385C (zh) 2003-05-30 2007-05-23 上海光明乳业股份有限公司 干酪乳杆菌Bd－II菌株及其在降低血脂方面的应用
US7279320B1 (en) 2003-06-20 2007-10-09 United States As Represented By The Secretary Of The Air Force Curlicue vaccine strain of Bacillus anthracis

Also Published As

Publication number Publication date
WO2004001022A1 (en) 2003-12-31
EP1527159A4 (en) 2006-10-04
US20050180963A1 (en) 2005-08-18
US7427397B2 (en) 2008-09-23
JP2005529960A (ja) 2005-10-06
EP1527159A1 (en) 2005-05-04
NZ537242A (en) 2008-10-31

Similar Documents

Publication Publication Date Title
JP4521687B2 (ja) プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２
TWI359668B (https=)
JP5709883B2 (ja) 新規なラクトバチルス・プランタラム及びこれを含む組成物
TW587098B (en) Immunity enhancing lactic acid bacteria
JP2022551680A (ja) Ｂｉｆｉｄｏｂａｃｔｅｒｉｕｍ ｂｒｅｖｅ ２０７－１およびその使用
WO2022218335A1 (zh) 罗伊氏乳杆菌及其应用、组合物、药物和食品
JP4712289B2 (ja) 免疫促進用組成物
EA031426B1 (ru) ПРИМЕНЕНИЕ Bifidobacterium lactis BL-04 ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ДЫХАТЕЛЬНЫХ ПУТЕЙ
Kneifel et al. Probiotics and health claims
CN106795482B (zh) 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物
JP5273695B2 (ja) ビフィズス菌を有効成分とするアレルギー予防および／または治療剤
CN111212575A (zh) 肌肉增量用组合物
KR20170105011A (ko) 비피더스균을 포함하는 면역조절 조성물
EP2220210B1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
TW201902499A (zh) 用於類鐸受體２活性化之組成物
Nishihira et al. Lactobacillus gasseri potentiates immune response against influenza virus infection
JP7225364B1 (ja) 乳酸菌
WO2020067422A1 (ja) Ｔ細胞を活性化するための組成物
WO2011099875A1 (en) Use of lactic acid bacteria to treat or prevent rhinitis
CN103987839B (zh) 能够抑制幽门螺杆菌菌株粘附至上皮细胞的新德式乳杆菌保加利亚亚种菌株
MX2011000658A (es) Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad.
EP2332557A1 (en) Probiotic lactic acid bacteria
Haris Modulation of immune system by taking probiotic bacteria: Especially focus on lactic acid bacteria
Crane Pro and anti: the biotics of allergic disease
JP7663240B2 (ja) 腸管免疫賦活剤及びＩｇＡ産生促進剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060619

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060707

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090630

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090928

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090929

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091005

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091210

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20091225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091225

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20100128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100324

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100420

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100517

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130604

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees